Dr. Amy Trottier will provide an overview of hereditary hematologic malignancy syndromes, with a focus on those that predispose to MDS or AML. Topics will include who, how, and when to test as well as what to do with the results. She will also present results of large scale germline genetic sequencing studies conducted on an unbiased international MDS population and highlight ongoing areas of research.